This announcement is a separate document:
和黃醫藥：和黃醫藥公佈2022年中期業績及最新業務進展
HUTCHMED: HUTCHMED Reports 2022 Interim Results and Provides Business Updates
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.